Level of fibronectin mRNA is markedly increased in human chronic wounds.
BACKGROUND
Acute wound healing has been extensively investigated over the years, however, little is known about possible healing defects in chronic wounds. Fibronectin (FN) plays a critical role in different phases of wound healing and has been demonstrated to be degraded in chronic wounds by proteases. Fibroblasts cultured from chronic leg ulcers showed a higher level of FN compared to normal fibroblasts.


OBJECTIVE
We explored whether the increase in FN protein in chronic wounds is due to increased FN mRNA. In addition, the level of alpha5beta1 integrin FN cell surface receptor was also examined.


METHODS
Skin biopsies were taken from normal skin within a few hours of Mohs surgery and from the edge of chronic venous leg ulcers. In situ hybridization was performed to determine the level of FN mRNA. The level of integrin alpha5beta1 was determined by immunohistochemistry.


RESULTS
The level of FN mRNA in normal skin and acute wounds was undetectable. In contrast, FN mRNA was heavily induced throughout the dermis of chronic wounds. Immunostaining using a monoclonal antibody against the alpha5 subunit of integrin revealed that chronic wounds and normal skin showed undetectable levels of alpha5beta1 integrin. A large induction of alpha5 was observed in acute wounds.


CONCLUSIONS
For reepithelization to occur, epidermal keratinocytes need to migrate over the wound surface, a process requiring an interaction between FN and its cell surface receptor integrin alpha5beta1. These findings suggest that although FN mRNA is increased in chronic wounds, lack of FN cell surface receptor may prevent migration of epidermal keratinocytes in chronic wounds.
Ongenae
K C
KC
Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Phillips
T J
TJ
Park
H Y
HY
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D002908:Chronic Disease; D015342:DNA Probes; D005260:Female; D005353:Fibronectins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007871:Leg Ulcer / Q000378:metabolism* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D015580:Mohs Surgery; D012333:RNA, Messenger / Q000378:metabolism; D017469:Receptors, Fibronectin / Q000235:genetics / Q000378:metabolism*; D012867:Skin / Q000378:metabolism*; D015854:Up-Regulation; D014945:Wound Healing
D015342:DNA Probes; D005353:Fibronectins; D012333:RNA, Messenger; D017469:Receptors, Fibronectin